Overview
BMO ARK Genomic Revolution Fund (ARKG) is managed by BMO. The fund was launched on 2022-11-17 and trades on the Cboe Stock Exchange.
Fund Details
- Category: NA
- General Category: None
- Expense Ratio: None
- Assets Under Management: $4M
- Actively Managed: Yes
- SEC CIK Code: 0001579982
- Benchmark: N/A
Investment Strategy
This None fund is actively managed and tracks the N/A.